InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| ODN 2006 (ODN 7909) | UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNA... | 2021 | PLoS One | Kim H. et al. | DOI: 10.1371/journal.pone.0258989 |
| LPS-EK (LPS from E. coli K12) | UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNA... | 2021 | PLoS One | Kim H. et al. | DOI: 10.1371/journal.pone.0258989 |
| 2'3'-cGAMP | UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNA... | 2021 | PLoS One | Kim H. et al. | DOI: 10.1371/journal.pone.0258989 |
| Imiquimod (R837) | UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNA... | 2021 | PLoS One | Kim H. et al. | DOI: 10.1371/journal.pone.0258989 |
| Pam3CSK4 | UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNA... | 2021 | PLoS One | Kim H. et al. | DOI: 10.1371/journal.pone.0258989 |
| Poly(I:C) (HMW) VacciGrade™ | UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNA... | 2021 | PLoS One | Kim H. et al. | DOI: 10.1371/journal.pone.0258989 |
| Human ACE2 expressing A549 Cells | Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for ... | 2021 | Viruses | Zhou Y. et al. | DOI: 10.3390/v13102082 |
| LPS-EK (LPS from E. coli K12) | 3D Model of the Early Melanoma Microenvironment Captures Macrophage Transitio... | 2021 | Cancers (Basel). | Pizzurro G.A. et al. | DOI: 10.3390/cancers13184579 |
| ODN 2006 (ODN 7909) | Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosi... | 2021 | Rheumatol Int. | Gernert M. et al. | DOI: 10.1007/s00296-021-05034-8 |
| G418 (Geneticin) | LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal D... | 2021 | Pathobiology | Dionísio de Sousa I.J. et al. | DOI: 10.1159/000517372 |
| R848 (Resiquimod) | X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Pati... | 2021 | J Clin Immunol. | Abolhassani H. et al. | DOI: 10.1007/s10875-021-01151-y |
| CL264 | X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Pati... | 2021 | J Clin Immunol. | Abolhassani H. et al. | DOI: 10.1007/s10875-021-01151-y |
| LPS-EK (LPS from E. coli K12) | An Atypical Autoinflammatory Disease Due to an LRR Domain NLRP3 Mutation Enha... | 2021 | J Clin Immunol. | Caseley E.A. et al. | DOI: 10.1007/s10875-021-01161-w |
| ATP | An Atypical Autoinflammatory Disease Due to an LRR Domain NLRP3 Mutation Enha... | 2021 | J Clin Immunol. | Caseley E.A. et al. | DOI: 10.1007/s10875-021-01161-w |
| Normocin® - Antimicrobial Reagent | Complexities of the chemogenetic toolkit: Differential mDAAO activation by d-... | 2021 | Free Radic Biol Med. | Erdogan Y.C. et al. | DOI: 10.1016/j.freeradbiomed.2021.10.023 |
| Alhydrogel® adjuvant 2% | Experimental evaluation of protection and immunogenicity of Streptococcus sui... | 2021 | Vet Res. | Obradovic M.R. et al. | DOI: 10.1186/s13567-021-01004-x |
| Puromycin | Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in i... | 2021 | Mol Ther Nucleic Acids | Hashimoto R. et al. | DOI: 10.1016/j.omtn.2021.10.016 |
| IL-12 Reporter HEK 293 Cells | Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids ... | 2021 | Pharmaceutics | Kos S. et al. | DOI: 10.3390/pharmaceutics13101739 |
| HEK-Blue™ Selection | Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids ... | 2021 | Pharmaceutics | Kos S. et al. | DOI: 10.3390/pharmaceutics13101739 |
| IL12elasti (p35::p40) | Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids ... | 2021 | Pharmaceutics | Kos S. et al. | DOI: 10.3390/pharmaceutics13101739 |